Bfactory Health Products BV

Name

Bfactory Health Products BV

Legal name

Bfactory Health Products B.V.

Website

https://bfactory.nl

Company type

Private

Operating status

Operating

Headcount range

1–10 employees

Ownership category

akta.pro rank

Product category

Medical Skincare and Wound Care Products

NAICS

Apiculture (112910)

SIC

Medicinal Chemicals & Botanical Products (2833), Perfumes, Cosmetics & Other Toilet Preparations (2844)

akta.pro primary industry

Value-Added Bee Products Manufacturing (Candles, Cosmetics, Supplements, Mead Ingredients) (AFAEAHAM)

akta.pro secondary industries

Dermatology & Allergy Drugs (HLAMAEAH), Antibacterial & Medicated Cleansers (e.g., Acne, Antifungal, Antiseptic) (CRABAEAH)

Keywords

• Honey-based wound care
• Medicinal skincare products
• Veterinary wound care
• Antimicrobial natural products
• Medical honey formulations

Headquarters

HQ city

Rhenen

HQ country

Netherlands

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Personnel, Operations, Technology or R&D, Marketing or Sales

Revenue model

1. Product Sales: Bfactory generates revenue through the sale of its honey-based health products under three brand portfolios: Revamil® (medical products for human wound care), Dermagiq® (cosmetic and skincare products), and Vetramil® (veterinary products). Products are distributed through exclusive regional distributors and online channels.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels3 records

Core offering

Bfactory Health Products BV develops, produces and distributes honey-based medical, cosmetic, and veterinary health products under three brand portfolios: Revamil® (medical-grade wound care products for humans), Dermagiq® (skincare and cosmetic products for skin disorders such as atopic eczema), and Vetramil® (veterinary wound care and skin products for animals). The products leverage the antibacterial properties of standardized medicinal honey sourced from healthy bee populations and are sold through exclusive regional distributors in more than 25 countries as well as directly through an online shop.

Product overview

Bfactory Health Products BV develops and produces honey-based products for human and animal health. The company operates under three distinct brands: Revamil® for medical/human wound care applications, Dermagiq® for cosmetic and skincare products, and Vetramil® for veterinary applications. All products leverage the antibacterial properties of medicinal honey to address skin and wound-related problems including acute and chronic wounds (infected and non-infected), atopic eczema, and other skin disorders. The products are developed using insights from scientific research at Wageningen University and are sold in more than 25 countries through exclusive distributors.

Differentiator

Problem solved

Functional benefit

Brands

• Revamil®: Medical products - honey-based wound care and medical applications.
• Dermagiq®
• Vetramil®

Products and services

• Revamil® Medical brand offering honey-based wound care products for humans, including wound dressings and balms designed for acute and chronic wounds (infected and non-infected) and related skin indications. Targeted at patients and healthcare professionals and distributed via exclusive regional distributors and online channels.
• Dermagiq® Cosmetic and skincare brand offering honey-based skin care products, including ointment formulations intended for atopic eczema and other skin disorders. Targeted at consumers seeking nature-based skincare with antibacterial honey properties.
• Vetramil® Veterinary brand offering honey-based products for animal wound care and skin disorders. Targeted at veterinarians, animal owners, and livestock keepers seeking antibacterial natural wound care solutions for animals.
• Revamil Balm Sachet Honey-based balm product for wound care, supplied in sachet format with electronic instructions for use (eIFU) accessible via QR code on packaging. Targeted at human wound care users and healthcare professionals.
• Dermagiq Skin® ointment Honey-based ointment for the treatment of atopic eczema and other skin disorders under the Dermagiq® brand. Targeted at consumers with skin disorders seeking nature-based antibacterial skincare.

Quantifiable outcome

• Honey has been shown to have bactericidal activity against bacteria involved with well-known diseases

Segments1 record

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Partnerships

Three partnerships are on record, tiered core and minor.

• Wageningen UniversitycoreStrategic or Co-development PartnerBfactory uses insights developed by scientific research at Wageningen University for product development. This academic partnership provides the scientific foundation for the company's honey-based health products, ensuring evidence-based product development for wound care and skincare applications.
• Light for the World FoundationminorOthersBfactory supports the foundation 'Light for the World' which is devoted to provide opportunities for people with a handicap living in underdeveloped countries. Additionally, Bfactory supports a program to train people with handicaps in Africa to become bee-keepers.
• Exclusive Regional DistributorscoreChannel Partner/ Reseller/ DistributorBfactory works with dedicated, committed, exclusive distributors in geographic regions. Products are currently sold in more than 25 countries through this distribution network.

Scale indicators1 record

Recent moves5 records

Expansion highlights4 records

Broad incumbents

• Smith & Nephew: Global medical technology company with a major Advanced Wound Management division offering a wide range of wound care products. Comparable to Bfactory as the dominant incumbent competitor in the broader wound care category where Revamil products compete.
• Mölnlycke Health Care: Swedish medical device company specializing in wound care and surgical solutions. Comparable to Bfactory as a major established wound care player against whose standard products Bfactory's honey-based alternatives compete for clinical adoption.
• Coloplast: Danish multinational that produces wound care and skincare products through its Wound & Skin Care division. Comparable to Bfactory as a large Nordic competitor whose conventional wound dressings compete against Revamil medical honey products.
• Dechra Pharmaceuticals: UK veterinary pharmaceuticals company providing specialty medicines and skin care products for animals. Comparable to Bfactory as a broader veterinary health incumbent competing with the Vetramil brand in animal wound and skin care applications.
• Convatec: UK-based global medical products company with significant wound care and skin care portfolios. Comparable to Bfactory as an incumbent competitor providing conventional wound care and skincare products that compete with Revamil and Dermagiq brands.
• Integra LifeSciences (Medihoney): Global medical device company that markets Medihoney wound care dressings through its Integra LifeSciences subsidiary. Comparable to Bfactory as a broader wound care incumbent that has commercialized medical honey products at greater scale across hospital channels.

Direct peers

• Manuka Health New Zealand: Producer of medical-grade manuka honey products for wound care, skincare, and health applications. Highly comparable to Bfactory in its use of scientifically validated honey with antibacterial properties for therapeutic and cosmetic end-uses.
• L-Mesitran (formerly Triticum): Dutch company that develops honey-based wound care products for both human and veterinary use. Directly comparable to Bfactory as a European competitor in the medicinal honey wound care space, particularly overlapping with the Revamil and Vetramil product lines.
• Comvita: New Zealand-based company that develops and markets manuka honey-based health products, including medical-grade wound care dressings and skincare. Directly comparable to Bfactory due to its bee-derived medicinal product focus across human health applications.

Emerging players

• ApiHealth (New Zealand): New Zealand-based company developing bioactive honey ingredients for skincare and therapeutic applications. Comparable to Bfactory as an emerging peer in the science-driven, value-added bee products space targeting cosmetic and medical end-uses.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xx.com/Dermagiq_nl
• Facebookfacebook.com/dermagiq
• Instagraminstagram.com/dermagiq
• LinkedInlinkedin.com/company/bfactory-health-products-bv

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Bfactory Health Products BV